Skip to main content
Account

Peer review reports

From: Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial

Original Submission
7 Feb 2023 Submitted Original manuscript
1 Mar 2023 Reviewed Reviewer Report
5 Mar 2023 Reviewed Reviewer Report
29 Jun 2023 Author responded Author comments - Joanne Chiu
Resubmission - Version 2
29 Jun 2023 Submitted Manuscript version 2
2 Jul 2023 Reviewed Reviewer Report
28 Jul 2023 Author responded Author comments - Joanne Chiu
Resubmission - Version 3
28 Jul 2023 Submitted Manuscript version 3
1 Aug 2023 Author responded Author comments - Joanne Chiu
Resubmission - Version 4
1 Aug 2023 Submitted Manuscript version 4
Publishing
1 Aug 2023 Editorially accepted
15 Aug 2023 Article published 10.1186/s12916-023-03017-z

Learn about peer review

Back to article page

Navigation